Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Weonsang Ro

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Liver Cancer|June 29, 2023
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular CarcinomaHyuk Moon, Simon Weonsang Ro
Cancers|July 2, 2021
MAPK/ERK Signaling Pathway in Hepatocellular CarcinomaHyuk Moon, Simon Weonsang Ro
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|August 2, 2016
Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinomaHye-Lim Ju, Simon Weonsang Ro
Anticancer Research|October 1, 2021
c-Myc-driven HepatocarcinogenesisHyuk Moon, Hyunjung Park, Simon Weonsang Ro
BMB Reports|October 26, 2017
Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of SnailHyuk Moon, Kwang-Hyub Han, Simon Weonsang Ro
Pharmaceutics|October 29, 2025
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer TherapyHyuk Moon, Hyunjung Park, Soyun Lee, et al.
Biology|April 23, 2022
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint InhibitorsHyunjung Park, Hyerin Park, Jiyeon Baek, et al.
Pharmaceutics|August 26, 2023
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular CarcinomaJieun Bang, Mihyeon Jun, Soyun Lee, et al.
International Journal of Molecular Sciences|September 28, 2023
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic ImplicationsHyunjung Park, Sangjik Lee, Jaehun Lee, et al.
International Journal of Cancer|July 30, 2015
Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapyHye-Lim Ju, Kwang-Hyub Han, Jong Doo Lee, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Liver Cancer|June 29, 2023
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular CarcinomaHyuk Moon, Simon Weonsang Ro
Cancers|July 2, 2021
MAPK/ERK Signaling Pathway in Hepatocellular CarcinomaHyuk Moon, Simon Weonsang Ro
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|August 2, 2016
Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinomaHye-Lim Ju, Simon Weonsang Ro
Anticancer Research|October 1, 2021
c-Myc-driven HepatocarcinogenesisHyuk Moon, Hyunjung Park, Simon Weonsang Ro
BMB Reports|October 26, 2017
Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of SnailHyuk Moon, Kwang-Hyub Han, Simon Weonsang Ro
Pharmaceutics|October 29, 2025
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer TherapyHyuk Moon, Hyunjung Park, Soyun Lee, et al.
Biology|April 23, 2022
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint InhibitorsHyunjung Park, Hyerin Park, Jiyeon Baek, et al.
Pharmaceutics|August 26, 2023
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular CarcinomaJieun Bang, Mihyeon Jun, Soyun Lee, et al.
International Journal of Molecular Sciences|September 28, 2023
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic ImplicationsHyunjung Park, Sangjik Lee, Jaehun Lee, et al.
International Journal of Cancer|July 30, 2015
Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapyHye-Lim Ju, Kwang-Hyub Han, Jong Doo Lee, et al.
Pageof 4